Antifungal policy and practice across five countries: A qualitative review
The study examines the global policy landscape for invasive fungal infections, identifies key policy gaps, and underscores the need for stronger policy...
Artes Haderi
Principal
Related capabilities
Related capabilities
Selected engagements
- 01Characterizing the new access landscapes for digital health innovationOur client was seeking to analysis better understand e-health funding and reimbursement policies and how each country’s current healthcare system support the...View engagement
- 02Public affairs toolkit on critical policy issues for gene therapiesGiven the increasing number of government and stakeholder debates and forums around gene therapies, a global pharmaceutical company asked CRA to set out the...View engagement
- 03CRA evaluates damages for alleged improper grant of patent sublicenseCRA provided an expert opinion on damages in breach of contract litigation concerning the alleged improper grant of a patent sublicense. CRA identified the...View engagement
Recent events
- Life Sciences
- Sponsorship & Speaking Engagement
- March 5-6, 2025
- Amsterdam, Netherlands
World EPA Congress
CRA is a proud sponsor of the event covering market access, pricing, reimbursement, rare diseases, health technology assessments, health economics and outcomes...
- Life Sciences
- Speaking Engagement
- October 30, 2024
- Webinar
The Burden of Time: MS Treatment and Socio-Economic Impact Reduction
The webinar participants explored the broader implications of timely access to effective treatments on patients, caregivers, and society.
Credentials
- London School of Economics and Political ScienceMSc, Management and Strategy
- Utrecht UniversityBSc, Economics and Business Economics
Get In Touch
Artes Haderi